• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非锌介导的碳酸酐酶抑制作用:香豆素是一类新型的自杀抑制剂。

Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors.

机构信息

Università degli Studi di Firenze, Laboratorio di Chimica Bioinorganica, Rm. 188, Via della Lastruccia 3, I-50019 Sesto Fiorentino, Florence, Italy.

出版信息

J Am Chem Soc. 2009 Mar 4;131(8):3057-62. doi: 10.1021/ja809683v.

DOI:10.1021/ja809683v
PMID:19206230
Abstract

The X-ray crystal structure of the adduct between the zinc metalloenzyme carbonic anhydrase II (CA, EC 4.2.1.1) with the recently discovered natural product coumarin derivative 6-(1S-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one showed the coumarin hydrolysis product, a cis-2-hydroxy-cinnamic acid derivative, and not the parent coumarin, bound within the enzyme active site. The bound inhibitor exhibits an extended, two-arm conformation that effectively plugs the entrance to the enzyme active site with no interactions with the catalytically crucial zinc ion. The inhibitor is sandwiched between Phe131, with which it makes an edge-to-face stacking, and Asn67/Glu238sym, with which it makes several polar and hydrogen bonding interactions. This unusual binding mode, with no interactions between the inhibitor molecule and the active site metal ion is previously unobserved for this enzyme class and presents a new opportunity for future drug design campaigns to target a mode of inhibition that differs substantially from classical inhibitors such as the clinically used sulfonamides and sulfamates. Several structurally simple coumarin scaffolds were also shown to inhibit all 13 catalytically active mammalian CA isoforms, with inhibition constants ranging from nanomolar to millimolar. The inhibition is time dependent, with maximum inhibition being observed after 6 h.

摘要

锌金属酶碳酸酐酶 II(CA,EC 4.2.1.1)与最近发现的天然产物香豆素衍生物 6-(1S-羟基-3-甲基丁基)-7-甲氧基-2H-色烯-2-酮的加合物的 X 射线晶体结构显示,香豆素水解产物顺式-2-羟基肉桂酸衍生物而不是母体香豆素结合在酶活性部位内。结合的抑制剂呈现出伸展的双臂构象,有效地阻塞了酶活性部位的入口,与催化关键的锌离子没有相互作用。抑制剂夹在 Phe131 之间,与 Phe131 形成边缘到面的堆积,与 Asn67/Glu238sym 形成几个极性和氢键相互作用。这种不寻常的结合模式,抑制剂分子与活性部位金属离子之间没有相互作用,以前在这种酶类中没有观察到,为未来的药物设计活动提供了一个新的机会,可以针对与经典抑制剂(如临床使用的磺胺类和磺胺酸盐)有很大不同的抑制模式。还显示几种结构简单的香豆素支架抑制所有 13 种催化活性的哺乳动物 CA 同工酶,抑制常数范围从纳摩尔到毫摩尔。抑制是时间依赖性的,在 6 小时后观察到最大抑制。

相似文献

1
Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors.非锌介导的碳酸酐酶抑制作用:香豆素是一类新型的自杀抑制剂。
J Am Chem Soc. 2009 Mar 4;131(8):3057-62. doi: 10.1021/ja809683v.
2
The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors.碳酸酐酶中的香豆素结合位点能够容纳结构多样的抑制剂:以抗癫痫药拉科酰胺为例,它是新型碳酸酐酶抑制剂的先导化合物。
J Med Chem. 2010 Jan 28;53(2):850-4. doi: 10.1021/jm901524f.
3
Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.碳酸酐酶抑制剂:与结构相关的环氧化酶II“选择性”抑制剂塞来昔布相比,伐地考昔与人同工型II的不同活性位点区域结合。
Bioorg Med Chem Lett. 2006 Jan 15;16(2):437-42. doi: 10.1016/j.bmcl.2005.09.040. Epub 2005 Nov 14.
4
Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations.二硫代氨基甲酸盐:一类新型碳酸酐酶抑制剂。晶体学和动力学研究。
Chem Commun (Camb). 2012 Feb 11;48(13):1868-70. doi: 10.1039/c2cc16395k. Epub 2012 Jan 5.
5
Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins.解析香豆素和噻吩并[3,2-d]嘧啶酮抑制碳酸酐酶的机制。
J Med Chem. 2010 Jan 14;53(1):335-44. doi: 10.1021/jm901287j.
6
Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV).碳酸酐酶抑制剂:酚类与12种具有催化活性的哺乳动物同工型(CA I-XIV)的相互作用。
Bioorg Med Chem Lett. 2008 Mar 1;18(5):1583-7. doi: 10.1016/j.bmcl.2008.01.077. Epub 2008 Jan 26.
7
Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.碳酸酐酶抑制剂。2-N,N-二甲基氨基-1,3,4-噻二唑-5-甲磺酰胺与12种哺乳动物同工型的相互作用:动力学和X射线晶体学研究。
Bioorg Med Chem Lett. 2008 Feb 1;18(3):999-1005. doi: 10.1016/j.bmcl.2007.12.022. Epub 2007 Dec 15.
8
Nanoscale enzyme inhibitors: fullerenes inhibit carbonic anhydrase by occluding the active site entrance.纳米级酶抑制剂:富勒烯通过阻塞活性部位入口来抑制碳酸酐酶。
Bioorg Med Chem. 2010 Apr 15;18(8):2822-8. doi: 10.1016/j.bmc.2010.03.026. Epub 2010 Mar 15.
9
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.多胺通过锚定锌配位的水分子来抑制碳酸酐酶。
J Med Chem. 2010 Aug 12;53(15):5511-22. doi: 10.1021/jm1003667.
10
Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.基于酚的碳酸酐酶同工酶 I、II、IX 和 XII 的抑制剂的动力学和对接研究为酶活性位点内的新结合模式提供了证据。
Bioorg Med Chem. 2011 Feb 15;19(4):1381-9. doi: 10.1016/j.bmc.2011.01.016. Epub 2011 Jan 14.

引用本文的文献

1
Computational Discovery of Selective Carbonic Anhydrase IX (CA IX) Inhibitors via Pharmacophore Modeling and Molecular Simulations for Cancer Therapy.通过药效团建模和分子模拟进行选择性碳酸酐酶IX(CA IX)抑制剂的计算发现用于癌症治疗
Int J Mol Sci. 2025 Aug 30;26(17):8465. doi: 10.3390/ijms26178465.
2
Selective Inhibition of Carbonic Anhydrase IX and XII by Natural Coumarin Coladonin and Its Derivatives: Promising Antimelanoma and Antiglioblastoma Agents.天然香豆素类化合物可乐豆素及其衍生物对碳酸酐酶IX和XII的选择性抑制作用:有前景的抗黑色素瘤和抗胶质母细胞瘤药物
ACS Med Chem Lett. 2025 May 19;16(6):1190-1196. doi: 10.1021/acsmedchemlett.5c00235. eCollection 2025 Jun 12.
3
Design, synthesis, molecular modelling investigation and biological studies of novel human carbonic anhydrase inhibitors based on coumalic acid.
基于香豆酸的新型人类碳酸酐酶抑制剂的设计、合成、分子模拟研究及生物学研究
RSC Med Chem. 2025 May 30. doi: 10.1039/d5md00208g.
4
In Vitro Evaluation of Novel Furo[3,2-]coumarins as Cholinesterases and Monoamine Oxidases Inhibitors.新型呋喃并[3,2 - ]香豆素作为胆碱酯酶和单胺氧化酶抑制剂的体外评价
Molecules. 2025 Apr 18;30(8):1830. doi: 10.3390/molecules30081830.
5
Investigation on Human Carbonic Anhydrase IX and XII Inhibitory Activity and A549 Antiproliferative Activity of a New Class of Coumarinamides.新型香豆素酰胺类化合物对人碳酸酐酶IX和XII的抑制活性及对A549细胞的抗增殖活性研究
Pharmaceuticals (Basel). 2025 Mar 5;18(3):372. doi: 10.3390/ph18030372.
6
Synthetic strategies and medicinal chemistry perspectives of dual acting carbonic anhydrase modulators with monoamine oxidase and cholinesterase inhibitors.兼具单胺氧化酶和胆碱酯酶抑制剂功能的双效碳酸酐酶调节剂的合成策略与药物化学展望
RSC Med Chem. 2025 Feb 6. doi: 10.1039/d4md00837e.
7
The Antiepileptic Drug Levetiracetam Inhibits Carbonic Anhydrase: and Studies on Catalytically Active Human Isoforms.抗癫痫药物左乙拉西坦抑制碳酸酐酶:及对具有催化活性的人类同工型的研究
ACS Med Chem Lett. 2024 Nov 11;15(12):2133-2139. doi: 10.1021/acsmedchemlett.4c00380. eCollection 2024 Dec 12.
8
Lactonase activity of α-carbonic anhydrases allows identification of novel inhibitors.α-碳酸酐酶的内酯酶活性有助于鉴定新型抑制剂。
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400705. doi: 10.1002/ardp.202400705. Epub 2024 Dec 9.
9
The carbonic anhydrase enzymes as new targets for the management of neglected tropical diseases.碳酸酐酶作为被忽视热带病治疗的新靶点。
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400626. doi: 10.1002/ardp.202400626. Epub 2024 Nov 9.
10
Novel 3-substituted coumarins inspire a custom pharmacology prediction pipeline: an anticancer discovery adventure.新型3-取代香豆素催生了一个定制的药理预测流程:一场抗癌发现之旅。
Future Med Chem. 2024;16(17):1761-1776. doi: 10.1080/17568919.2024.2379232. Epub 2024 Sep 4.